Using a Modified Lymphocyte Genome Sensitivity (LGS) test or TumorScan test to detect cancer at an early stage in each individual.
- DOI
- 10.1096/fba.1020
- Published
- 2019 Jan
- Container
- FASEB bioAdvances
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1096/fba.1020,
title = {Using a Modified Lymphocyte Genome Sensitivity (LGS) test or TumorScan test to detect cancer at an early stage in each individual.},
author = {Anderson D and Najafzadeh M and Scally A and Jacob B and Griffith J and Chaha R and Linforth R and Soussaline M and Soussaline F},
year = {2019},
journal = {FASEB bioAdvances},
doi = {10.1096/fba.1020},
url = {https://doi.org/10.1096/fba.1020}
}RIS
TY - JOUR TI - Using a Modified Lymphocyte Genome Sensitivity (LGS) test or TumorScan test to detect cancer at an early stage in each individual. AU - Anderson D AU - Najafzadeh M AU - Scally A AU - Jacob B AU - Griffith J AU - Chaha R AU - Linforth R AU - Soussaline M AU - Soussaline F PY - 2019 JO - FASEB bioAdvances DO - 10.1096/fba.1020 UR - https://doi.org/10.1096/fba.1020 ER -
APA
D, A., M, N., A, S., B, J., J, G., R, C., R, L., M, S., & F, S. (2019). Using a Modified Lymphocyte Genome Sensitivity (LGS) test or TumorScan test to detect cancer at an early stage in each individual.. FASEB bioAdvances. https://doi.org/10.1096/fba.1020
Source records
- pubmed · retrieved 2026-09-26T19:12:02.864Z